Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | Farallon Capital Partners, L.P. | Forte Biosciences, Inc. | 633,514 | 1.7% | EDGAR |
SC 13G/A | 2024-02-14 | ALGER ASSOCIATES INC | Forte Biosciences, Inc. | 1,838,965 | 5.1% | EDGAR |
SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Forte Biosciences, Inc. | 3,633,635 | 9.9% | EDGAR |
SC 13G | 2024-02-14 | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | Forte Biosciences, Inc. | 3,630,468 | 10.0% | EDGAR |
SC 13D/A | 2024-01-11 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 1,761,702 | 4.8% | EDGAR |
SC 13D/A | 2024-01-09 | Funicular Funds, LP | Forte Biosciences, Inc. | 2,031,987 | 5.6% | EDGAR |
SC 13D/A | 2024-01-05 | Camac Fund, LP | Forte Biosciences, Inc. | 1,577,176 | 4.3% | EDGAR |
SC 13D/A | 2023-09-15 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 1,735,075 | 4.8% | EDGAR |
SC 13G | 2023-09-12 | ALGER ASSOCIATES INC | Forte Biosciences, Inc. | 1,838,965 | 5.1% | EDGAR |
SC 13G | 2023-09-08 | PERCEPTIVE ADVISORS LLC | Forte Biosciences, Inc. | 3,627,775 | 9.9% | EDGAR |
SC 13D | 2023-08-23 | Camac Fund, LP | Forte Biosciences, Inc. | 1,577,176 | 4.3% | EDGAR |
SC 13D/A | 2023-08-15 | Wagner Paul A. | Forte Biosciences, Inc. | 1,901,199 | 5.2% | EDGAR |
SC 13D/A | 2023-08-10 | ATG Fund II LLC | Forte Biosciences, Inc. | 1,462,000 | 4.0% | EDGAR |
SC 13G | 2023-08-10 | Farallon Capital Partners, L.P. | Forte Biosciences, Inc. | 632,535 | 1.7% | EDGAR |
SC 13G | 2023-08-10 | BIOTECHNOLOGY VALUE FUND L P | Forte Biosciences, Inc. | 1,589,896 | 4.4% | EDGAR |
SC 13D/A | 2023-08-03 | Camac Fund, LP | Forte Biosciences, Inc. | 1,316,784 | 3.6% | EDGAR |
SC 13D/A | 2023-07-06 | Funicular Funds, LP | Forte Biosciences, Inc. | 2,031,987 | 9.6% | EDGAR |
SC 13D/A | 2023-07-05 | Camac Fund, LP | Forte Biosciences, Inc. | 1,812,712 | 8.6% | EDGAR |
SC 13D/A | 2023-05-25 | Camac Fund, LP | Forte Biosciences, Inc. | 1,812,712 | 8.6% | EDGAR |
SC 13G | 2023-04-10 | JEC II Associates, LLC | Forte Biosciences, Inc. | 1,141,000 | 5.4% | EDGAR |